PAMAM dendrimer roles in gene delivery methods and stem cell research

Cell Biology International

Volumn 37, Issue 5, 2013, Pages 415-419

  Daneshvar, Nasibeh ^a   Abdullah, Rasedee ^a   Shamsabadi, Fatemeh T ^a   How, Chee Wun ^a   Aizat, M M H ^a   Mehrbod, Parvaneh ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Gene delivery; PAMAM dendrimer; Stem cell

Indexed keywords

DENDRIMER; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; NANOPARTICLE; OCTAMER TRANSCRIPTION FACTOR 4; POLYAMIDOAMINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LIN28; TRANSCRIPTION FACTOR SOX2; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL POPULATION; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HETEROZYGOTE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR REPROGRAMMING; PARTICLE SIZE; PLURIPOTENT STEM CELL; SHORT SURVEY; STEM CELL RESEARCH;

EID: 84878118860     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10051     Document Type: Short Survey

References (49)

1. Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R (2008) Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2(2): 151-9.
2. Braun CS, Vetro J, Tomalia D, Koe GS, Koe JG, Middaugh CR (2005) Structure/function relationships of polyamidoamine/ DNA dendrimers as gene delivery vehicles. J Pharm Sci 94: 423-36.
3. Campbell KHS, Fisher P, Chen WC, Choi I, Kelly RDW, Lee J-H, Xhu J (2007) Somatic cell nuclear transfer: past, present and future perspectives. Theriogenology 68: 214-31.
4. Campbell KH, McWhir J, Ritchie WA, Wilmut I (1996) Sheep cloned by nuclear transfer from a cultured cell line. Nature 380(6569): 64-6.
5. Campbell KHS, Wilmut I (1997) Totipotency or multipotentiality of cultured cells: applications and progress. Theriogenology 47: 63-72.
6. Chauhan AS, Diwan PV, Jain NK, Tomalia D (2009) Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. Biomacromolecules 10: 1195-202.
7. Dey D, Evans GRD (2011) Generation of induced pluripotent stem (iPS) cells by nuclear reprogramming. Stem Cells Int 2011, 11.
8. Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, Meisner L, Zwaka TP, Thomson J, Andrews PW (2004) Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol 22: 53-4.
9. Duncan R, Izzo L (2005) Dendrimer biocompatibility and toxicity. Adv Drug Deliver Rev 57(15): 2215-37.
10. Dutta T, Jain NK, McMillan NJ, Parekh HS (2010) Retraction to "dendrimer nanocarriers as versatile vectors in gene delivery". Nanomedicine 6(1): 25-34.
11. Eliyahu H, Barenholz Y, Domb J (2005) Polymers for DNA delivery. Molecules 10(1): 34-64.
12. Fant K, Esbjörner EK, Lincoln P, Nordén B (2008) DNA condensation by PAMAM dendrimers: self-assembly characteristics and effect on transcription. Biochemistry 47: 1732-40.
13. Gurdon JB (1962) The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 10: 622-40.
14. Gurdon JB, Byrne JA (2003) The first half-century of nuclear transplantation. Proc Natl Acad Sci USA 24: 545-57.
15. Haensler J, Szoka FC Jr (1993) Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem 4(5): 372-9.
16. Hanna J, Markoulaki S, Schorderet P, Carey BW, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Lengner CJ, Dausman JA, Jaenisch R (2009) Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133: 250-64.
17. Hochedlinger K, Jaenisch R (2006) Nuclear reprogramming and pluripotency. Nature 441: 1061-7.
18. Huang C, Tang Z, Zhou Y, Zhou X, Jin Y, Li D, Yang Y, Zhou S (2012) Magnetic micelles as a potential platform for dual targeted drug delivery in cancer therapy. Int J Pharm 429: 113-22.
19. Iii WMR, Kyba M, George Q (2002) Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109: 17-27.
20. Jaenisch R, Young R (2008) Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132: 567-82.
21. Jain A, Dubey S, Kaushik A, Tyagi A (2010) Dendrimer: a complete drug carrier. Int J Pharm Sci Drug Res 1(4): 38-52.
22. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Robbins RC, Kay MA, Longaker MT, Wu JC (2010) A nonviral minicircle vector for deriving human iPS cells. Nat Methods 7: 197-9.
23. Klajnert B, Bryszewska M (2001) Dendrimers: properties and applications. Acta Biochim Pol 48: 199-208.
24. Kobayashi H, Brechbiel MW (2005) Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 57: 2271-86.
25. Krueger WH, Swanson LC, Tanasijevic B, Rasmussen TP (2010) Natural and artificial routes to pluripotency. Int J Dev Biol 54: 1545-64.
26. Lee CC, MacKay J, Fréchet JMJ, Szoka FC (2005) Designing dendrimers for biological applications. Nat Biotechnol 23: 1517-26.
27. Lohmann F, Loureiro J, Su H, Fang Q, Lei H, Lewis T, Yang Y, Labow M, Li E, Chen T, Kadam S (2010) KMT1E mediated H3K9 methylation is required for the maintenance of embryonic stem cells by repressing trophectoderm differentiation. Stem cells 28: 201-12.
28. Ma K, Hu M, Qi Y, Qiu L, Jin Y, Yu J, Li B (2009) Biomaterials structure - transfection activity relationships with glucocorticoid - polyethyl-enimine conjugate nuclear gene delivery systems. Biomaterials 30: 3780-9.
29. Marshall E (2002) Gene therapy a suspect inleukemia-like disease. Science 298(5591): 34-5.
30. Meshorer E, Yellajoshula D, George E, Scambler PJ, David T, Misteli T (2007) Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 10: 105-16.
31. Nakagawa M, KoyanagiM, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S (2008) Generation of induced pluripotent stem cells withoutMyc from mouse and human fibroblasts. Nat Biotechnol 26: 101-6.
32. Nori S, Okada Y, Yasuda A, Tsuji O, Takahashi Y, Kobayashi Y, Fujiyoshi K, Koike M, Uchiyama Y, Ikeda E, Toyama Y, Yamanaka S, Nakamura M, Okano H (2011) Grafted humaninduced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci USA 108: 16825-30.
33. Okamoto S, Takahashi M (2011) Induction of retinal pigment epithelial cells from monkey iPS cells. Invest Ophthalmol Vis Sci 52: 8785-90.
34. Rossant J (2008) Stem cells and early lineage development. Cell 132 (4): 527-31.
35. Ruan J, Shen J, Wang Z, Ji J, Song H, Wang K, Liu B, Li J, Cui D (2011) Efficient preparation and labeling of human induced pluripotent stem cells by nanotechnology. Int J Nanomed 6: 425-35.
36. Santos JL, Oliveira H, Pandita D, Rodrigues J, Pêgo AP, Granja PL, Tomás H (2010a) Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. J Control Release 144: 55-64.
37. Santos L, Pandita D, Pe AP, Granja PL, Balian G, Toma H (2010b) Receptor-mediated gene delivery using PAMAM dendrimers conjugated with peptides recognized by mesenchymal stem cells. Mol Pharm 7: 763-74.
38. Sarin H, Kanevsky AS,Wu H, Brimacombe KR, Fung SH, Sousa A, Auh S, Wilson CM, Sharma K, Aronova M, Leapman RD, Griffiths GL, Hall MD (2008) Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med 6: 15.
39. Stadtfeld M, Maherali N, Breault DT, Hochedlinger K (2008) Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2: 230-40.
40. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5): 861-72.
41. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 1-14.
42. Tang MX, Redemann CT, Szoka FC (1996) In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem 7: 703-14.
43. Thomas M, Klibanov M (2003) Non-viral gene therapy: polycation-mediated DNA delivery. Appl Microbiol Biotechnol 62: 27-34.
44. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P (1985) A new class of polymers: starburstdendritic macromolecules. Polym J 17: 117-32.
45. Tomalia DA, Reyna LA, Svenson S (2006) Dendrimers as multipurpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 35(1): 61-7.
46. Warnock JN, Daigre C, Al-rubeai M (2011) Introduction to viral vectors., In: Merten, O-W, Al-Rubeai, M, eds. Methods in molecular biology, Vol. 737. Totowa, NJ: Humana Press, pp. 1-25.
47. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-24.
48. Yamanaka S (2008) Pluripotency and nuclear reprogramming. Philos Trans R Soc 363: 2079-87.
49. Yu J, Vodyanik M, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir G, Ruotti V, Stewart R, Slukvin II, Thomson J (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-20.